Answers are grounded in this paper and cite their sources.
More data is urgently needed to establish evidence-based recommendations for the management of inflammatory heart disease.
in patients with active myocarditis In fact, it appears that patients with histological evidence for ongoing inflammation in the absence of residual viral genome in heart biopsy samples or evidence for heart-specific autoimmunity might benefit from immunosuppression. Antiviral treatment, on the other hand, might be beneficial for patients suffering from acute viral myocarditis Unfortunately, these studies were rather small and do not yet provide sufficient evidence to draw firm conclusions regarding generally accepted recommendations for the management of all patients with inflammatory heart disease. In order to translate recent progress in basic and preliminary clinical research into clinical practice, we therefore urgently need more data on these patients.
No takes yet. Share an insight, caveat, or question.
Urs Eriksson (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: